Anna Gaulton

22.1k citations

37 papers · 10.4k indexed · 8 hit papers · h-index 24

Impact in

Computational Theory and Mathematics top 0.02%
- Computational Drug Discovery Methods
Molecular Biology top 0.5%
- Bioinformatics and Genomic Networks
- Protein Structure and Dynamics
- Receptor Mechanisms and Signaling
- Metabolomics and Mass Spectrometry Studies
- Chemical Synthesis and Analysis

Papers in

Computational Theory and Mathematics 29
- Computational Drug Discovery Methods 29
Molecular Biology 32
- Bioinformatics and Genomic Networks 11
- Biomedical Text Mining and Ontologies 6
- Receptor Mechanisms and Signaling 6
- Metabolomics and Mass Spectrometry Studies 5
- Genetics, Bioinformatics, and Biomedical Research 5
- Protein Structure and Dynamics 4

Co-authors: John P. Overington Anne Hersey A. Patrícia Bento Louisa J. Bellis Mark Davies Jon Chambers Bissan Al‐Lazikani Yvonne Light
Journals: Nucleic Acids Research (8 papers)Journal of Cheminformatics (5 papers)Drug Discovery Today Technologies (3 papers)Drug Discovery Today (2 papers)Bioinformatics (2 papers)
Partner nations: United Kingdom United States Switzerland

In The Last Decade

Anna Gaulton

37 papers receiving 10.2k citations

Hit Papers

8 papers align trajectories log scale

The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods 2023 · 469 citations

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if any of the following hold:

it has ≥500 total citations;
it reaches ≥1.5× the top-1% citation threshold for papers in the same subfield and year (the threshold is the minimum needed to enter the top 1%, not the average within it);
it reaches the top citation threshold in at least one of its specific research topics.

2023 Nucleic Acids Research
2020 Journal of Cheminformatics
2017 Science Translational Medicine
2016 Nature Reviews Drug Discovery
2016 Nucleic Acids Research
2015 Nucleic Acids Research
2013 Nucleic Acids Research
2011 Nucleic Acids Research

Peers

Countries citing papers authored by Anna Gaulton

Since Specialization

Citations

This map shows the geographic impact of Anna Gaulton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Gaulton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Gaulton more than expected).

Fields of papers citing papers by Anna Gaulton

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Gaulton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Gaulton. The network helps show where Anna Gaulton may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Anna Gaulton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Anna Gaulton Line = papers co-authored together Anna Gaulton links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods Nucleic Acids Research ·Barbara Zdrazil, Eloy Félix, Fiona Hunter, Emma J. Manners, James Blackshaw, Sybilla Corbett, Marleen De Veij, Harris Ioannidis, David Méndez, Nerina Aguilera Gutiérrez, María Paula Magariños, Nicolas Bosc, Ricardo Arcila, Tevfik Kizilören, Anna Gaulton, A. Patrícia Bento, Melissa F. Adasme, Peter Monecke, Gregory A. Landrum, Andrew R. Leach Hit paper breakdown →	2023	469
2	Illuminating the druggable genome through patent bioactivity data PeerJ ·María Paula Magariños, Anna Gaulton, Eloy Félix, Tevfik Kizilören, Ricardo Arcila, Tudor I. Oprea, Andrew R. Leach	2023	6
3	An open source chemical structure curation pipeline using RDKit Journal of Cheminformatics ·A. Patrícia Bento, Anne Hersey, Eloy Félix, Gregory A. Landrum, Anna Gaulton, Francis Atkinson, Louisa J. Bellis, Marleen De Veij, Andrew R. Leach Hit paper breakdown →	2020	386
4	Improving the odds of drug development success through human genomics: modelling study Scientific Reports ·Aroon D. Hingorani, Valerie Kuan, Chris Finan, Felix Krüger, Anna Gaulton, Sandesh Chopade, Reecha Sofat, Raymond J. MacAllister, John P. Overington, Harry Hemingway, Spiros Denaxas, David Prieto‐Merino, Juan P. Casas	2019	129
5	A large-scale dataset of in vivo pharmacology assay results Scientific Data ·Fiona Hunter, Francis Atkinson, A. Patrícia Bento, Nicolas Bosc, Anna Gaulton, Anne Hersey, Andrew R. Leach	2018	10
6	A drug target slim: using gene ontology and gene ontology annotations to navigate protein-ligand target space in ChEMBL Journal of Biomedical Semantics ·Prudence Mutowo, A. Patrícia Bento, Nathan Dedman, Anna Gaulton, Anne Hersey, Jane Lomax, John P. Overington	2016	22
7	A comprehensive map of molecular drug targets Nature Reviews Drug Discovery ·Rita Santos, Oleg Ursu, Anna Gaulton, A. Patrícia Bento, Mahmoud Rocco Abdelouhab, Cristian Bologa, Anneli Karlsson, Bissan Al‐Lazikani, Anne Hersey, Tudor I. Oprea, John P. Overington Hit paper breakdown →	2016	1594
8	Managing expectations: assessment of chemistry databases generated by automated extraction of chemical structures from patents Journal of Cheminformatics ·Stefan Senger, Afkar Hussain, George Papadatos, Anna Gaulton	2015	13
9	Activity, assay and target data curation and quality in the ChEMBL database Journal of Computer-Aided Molecular Design ·George Papadatos, Anna Gaulton, Anne Hersey, John P. Overington	2015	108
10	ChEMBL web services: streamlining access to drug discovery data and utilities Nucleic Acids Research ·Mark Davies, Michał Nowotka, George Papadatos, Nathan Dedman, Anna Gaulton, Francis Atkinson, Louisa J. Bellis, John P. Overington Hit paper breakdown →	2015	464
11	SureChEMBL: a large-scale, chemically annotated patent document database Nucleic Acids Research ·George Papadatos, Mark Davies, Nathan Dedman, Jon Chambers, Anna Gaulton, Adriana Cristina Hilleshein, S. H. Chen, Sean A. Irvine, Maria Jansson, Anna Wernsmann, Anne Hersey, John P. Overington	2015	150
12	Transporter taxonomy – a comparison of different transport protein classification schemes Drug Discovery Today Technologies ·Maurílio Antônio Damacena Silva, Anna Gaulton, Daniela Digles, Gerhard F. Ecker	2014	2
13	Chemical, Target, and Bioactive Properties of Allosteric Modulation PLoS Computational Biology ·Gerard J. P. van Westen, Anna Gaulton, John P. Overington	2014	70
14	Transporter assays and assay ontologies: useful tools for drug discovery Drug Discovery Today Technologies ·Barbara Zdrazil, Christine Chichester, HITOSHI TAKAGI, Ola Engkvist, Anna Gaulton, John P. Overington	2014	5
15	The ChEMBL bioactivity database: an update Nucleic Acids Research ·A. Patrícia Bento, Anna Gaulton, Anne Hersey, Louisa J. Bellis, Jon Chambers, Mark Davies, Felix Krüger, Yvonne Light, Lora Mak, P. Hirunsri, Michał Nowotka, George Papadatos, Rita Santos, John P. Overington Hit paper breakdown →	2013	1117
16	UniChem: a unified chemical structure cross-referencing and identifier tracking system Journal of Cheminformatics ·Jon Chambers, Mark Davies, Anna Gaulton, Anne Hersey, Sameer Velankar, Robert Petryszak, Janna Hastings, Louisa J. Bellis, P. Hirunsri, John P. Overington	2013	115
17	Visualizing the drug target landscape Drug Discovery Today ·Stephen J. Campbell, Anna Gaulton, Jenny García-B., Н В Долотова, Francis Meloche, Cory Brouwer, Lee Harland	2011	5
18	Functional assignment of MAPK phosphatase domains Proteins Structure Function and Bioinformatics ·Rafael Ruiz de Gauna Torres, Pablo Ríos, Anna Gaulton, Rafael Pulido, Teresa K. Attwood, Lydia Tabernero	2007	11
19	Motif3D: relating protein sequence motifs to 3D structure Nucleic Acids Research ·Anna Gaulton	2003	10
20	Bioinformatics approaches for the classification of G-protein-coupled receptors Current Opinion in Pharmacology ·Anna Gaulton	2003	29

About Anna Gaulton

Anna Gaulton is a scholar working on Computational Theory and Mathematics, Molecular Biology, Pharmacology, Pharmacology and Biophysics, having authored 37 papers that have together received 10.4k indexed citations. Recurring topics across this work include Computational Drug Discovery Methods (29 papers), Bioinformatics and Genomic Networks (11 papers), Microbial Natural Products and Biosynthesis (7 papers), Biomedical Text Mining and Ontologies (6 papers), Receptor Mechanisms and Signaling (6 papers), Metabolomics and Mass Spectrometry Studies (5 papers), Genetics, Bioinformatics, and Biomedical Research (5 papers) and Protein Structure and Dynamics (4 papers). The work is most often cited by research in Computational Theory and Mathematics (6.0k citations), Molecular Biology (6.9k citations), Pharmacology (732 citations), Pharmacology (1.2k citations) and Biophysics (239 citations). Anna Gaulton has collaborated with scholars based in United Kingdom, United States and Switzerland. Frequent co-authors include John P. Overington, Anne Hersey, A. Patrícia Bento, Louisa J. Bellis, Mark Davies, Jon Chambers, Bissan Al‐Lazikani, Yvonne Light, George Papadatos and Anneli Karlsson. Their work appears in journals such as Nucleic Acids Research, Journal of Cheminformatics, Drug Discovery Today Technologies, Drug Discovery Today and Bioinformatics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact